Condition
Eosinophilic Gastrointestinal Disorders (EGIDs) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Eosinophilic Gastrointestinal Disorders (EGIDs) clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Dupilumab treatment for children with refractory eosinophilic gastrointestinal disorders
We will try subcutaneous dupilumab injections in children with refractory EGIDs to see if symptoms, tissue eosinophils, and tolerability improve.
-
Evaluating outcomes in eosinophilic gastrointestinal disorders
This study is trying to find the best ways to measure how well people with eosinophilic gastrointestinal disorders are doing by looking at their symptoms and tissue samples over time.
Related topics
Quick answers
How many Eosinophilic Gastrointestinal Disorders (EGIDs) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.